JAMA Surgery:伤口内撒万古霉素粉在治疗高危骨折手术中的作用

2021-03-31 MedSci原创 MedSci原创

尽管广泛使用全身性抗生素可以预防手术部位感染,降低骨科手术中钢板和螺钉固定骨折后的高感染率,但是抗生素只能输送到有足够血液供应的组织。

      尽管广泛使用全身性抗生素可以预防手术部位感染,降低骨科手术中钢板和螺钉固定骨折后的高感染率,但是抗生素只能输送到有足够血液供应的组织,而在骨折时,骨折部位的血供可能会在严重受伤的组织中受损,因此,局部抗生素疗法可以直接给骨折部位提供更高的浓度抗生素浓度,降低感染的发生。因此,本项研究进行了随机临床实验评估伤口内撒万古霉素粉末在减少深部骨折手术部位感染的效果。

      这项临床试验纳入了胫骨平台或枕骨骨折的成年患者,这些患者手术时间均在2015年1月1日至2017年6月30日之间, 所有患者均随机接受了有(n = 481)或无(n = 499)1000 mg伤口内万古霉素粉的标准感染预防方案的治疗。主要观察结果是在确定的骨折固定后182天内进行了深部手术部位感染的评估。其他次要结果包括浅表外科手术部位感染,骨不连和伤口裂开的情况。

该研究最后总共包括了980例患者(平均年龄,45.7岁; 617男性)。在182天之内,治疗组481例患者中有29例发生了深部手术部位感染,而对照组499例中有46例发生了深部手术部位感染。到事件发生时间,估计182天深层感染的可能性在治疗组中为6.4%,在对照组中为9.8%(风险差异为–3.4%; 95%CI为–6.9%至0.1%;P =. 06)。对革兰氏阳性和革兰氏阴性菌的治疗效果分析中发现万古霉素粉末的作用是主要抑制革兰氏阳性感染减少。

图:使用万古霉素患者分组情况展示

   

      本项研究证实在接受高风险感染的需手术治疗的胫骨关节骨折患者中,确定性骨折固定时伤口内撒万古霉素粉降低了革兰氏阳性深部手术部位感染的风险。

 

 

原始出处:

The Major Extremity Trauma Research Consortium. Effect of Intrawound Vancomycin Powder in Operatively Treated High-risk Tibia Fractures. JAMA Surg.2021.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1967935, encodeId=533b196e9355c, content=<a href='/topic/show?id=4e3e1952878' target=_blank style='color:#2F92EE;'>#万古霉素粉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19528, encryptionId=4e3e1952878, topicName=万古霉素粉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sat Nov 20 05:11:28 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877755, encodeId=2f4318e775588, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Fri Aug 06 07:11:28 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000753, encodeId=75801000e53d1, content=了解中, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/61a805a96cd14c7db6b101d616e016c1/9edf917c94b7459892b96b58b289c9a4.jpg, createdBy=3a415395963, createdName=杨楠要做大医生, createdTime=Sun Jul 18 23:51:48 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021704, encodeId=fa7e2021e04eb, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Sep 24 07:11:28 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952980, encodeId=34f8952980eb, content=是否合理可能还是要看结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Thu Apr 01 06:45:59 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952978, encodeId=910c9529e848, content=阿米卡星试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIRJ8uX1iaKrYl6YIzycoNZg7LibvSCM86rFq9L5JM0jkLJoPh7BPKka0JuiagKxNOfHCG9hbibCFpTQA/132, createdBy=1a801742301, createdName=Jenny6666, createdTime=Thu Apr 01 03:52:57 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036552, encodeId=fdb5103655285, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 01 02:11:28 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952962, encodeId=dec2952962c8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Wed Mar 31 23:24:38 CST 2021, time=2021-03-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1967935, encodeId=533b196e9355c, content=<a href='/topic/show?id=4e3e1952878' target=_blank style='color:#2F92EE;'>#万古霉素粉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19528, encryptionId=4e3e1952878, topicName=万古霉素粉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sat Nov 20 05:11:28 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877755, encodeId=2f4318e775588, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Fri Aug 06 07:11:28 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000753, encodeId=75801000e53d1, content=了解中, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/61a805a96cd14c7db6b101d616e016c1/9edf917c94b7459892b96b58b289c9a4.jpg, createdBy=3a415395963, createdName=杨楠要做大医生, createdTime=Sun Jul 18 23:51:48 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021704, encodeId=fa7e2021e04eb, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Sep 24 07:11:28 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952980, encodeId=34f8952980eb, content=是否合理可能还是要看结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Thu Apr 01 06:45:59 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952978, encodeId=910c9529e848, content=阿米卡星试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIRJ8uX1iaKrYl6YIzycoNZg7LibvSCM86rFq9L5JM0jkLJoPh7BPKka0JuiagKxNOfHCG9hbibCFpTQA/132, createdBy=1a801742301, createdName=Jenny6666, createdTime=Thu Apr 01 03:52:57 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036552, encodeId=fdb5103655285, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 01 02:11:28 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952962, encodeId=dec2952962c8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Wed Mar 31 23:24:38 CST 2021, time=2021-03-31, status=1, ipAttribution=)]
    2021-08-06 chg121
  3. [GetPortalCommentsPageByObjectIdResponse(id=1967935, encodeId=533b196e9355c, content=<a href='/topic/show?id=4e3e1952878' target=_blank style='color:#2F92EE;'>#万古霉素粉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19528, encryptionId=4e3e1952878, topicName=万古霉素粉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sat Nov 20 05:11:28 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877755, encodeId=2f4318e775588, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Fri Aug 06 07:11:28 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000753, encodeId=75801000e53d1, content=了解中, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/61a805a96cd14c7db6b101d616e016c1/9edf917c94b7459892b96b58b289c9a4.jpg, createdBy=3a415395963, createdName=杨楠要做大医生, createdTime=Sun Jul 18 23:51:48 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021704, encodeId=fa7e2021e04eb, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Sep 24 07:11:28 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952980, encodeId=34f8952980eb, content=是否合理可能还是要看结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Thu Apr 01 06:45:59 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952978, encodeId=910c9529e848, content=阿米卡星试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIRJ8uX1iaKrYl6YIzycoNZg7LibvSCM86rFq9L5JM0jkLJoPh7BPKka0JuiagKxNOfHCG9hbibCFpTQA/132, createdBy=1a801742301, createdName=Jenny6666, createdTime=Thu Apr 01 03:52:57 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036552, encodeId=fdb5103655285, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 01 02:11:28 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952962, encodeId=dec2952962c8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Wed Mar 31 23:24:38 CST 2021, time=2021-03-31, status=1, ipAttribution=)]
    2021-07-18 杨楠要做大医生

    了解中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1967935, encodeId=533b196e9355c, content=<a href='/topic/show?id=4e3e1952878' target=_blank style='color:#2F92EE;'>#万古霉素粉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19528, encryptionId=4e3e1952878, topicName=万古霉素粉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sat Nov 20 05:11:28 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877755, encodeId=2f4318e775588, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Fri Aug 06 07:11:28 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000753, encodeId=75801000e53d1, content=了解中, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/61a805a96cd14c7db6b101d616e016c1/9edf917c94b7459892b96b58b289c9a4.jpg, createdBy=3a415395963, createdName=杨楠要做大医生, createdTime=Sun Jul 18 23:51:48 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021704, encodeId=fa7e2021e04eb, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Sep 24 07:11:28 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952980, encodeId=34f8952980eb, content=是否合理可能还是要看结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Thu Apr 01 06:45:59 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952978, encodeId=910c9529e848, content=阿米卡星试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIRJ8uX1iaKrYl6YIzycoNZg7LibvSCM86rFq9L5JM0jkLJoPh7BPKka0JuiagKxNOfHCG9hbibCFpTQA/132, createdBy=1a801742301, createdName=Jenny6666, createdTime=Thu Apr 01 03:52:57 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036552, encodeId=fdb5103655285, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 01 02:11:28 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952962, encodeId=dec2952962c8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Wed Mar 31 23:24:38 CST 2021, time=2021-03-31, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1967935, encodeId=533b196e9355c, content=<a href='/topic/show?id=4e3e1952878' target=_blank style='color:#2F92EE;'>#万古霉素粉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19528, encryptionId=4e3e1952878, topicName=万古霉素粉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sat Nov 20 05:11:28 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877755, encodeId=2f4318e775588, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Fri Aug 06 07:11:28 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000753, encodeId=75801000e53d1, content=了解中, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/61a805a96cd14c7db6b101d616e016c1/9edf917c94b7459892b96b58b289c9a4.jpg, createdBy=3a415395963, createdName=杨楠要做大医生, createdTime=Sun Jul 18 23:51:48 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021704, encodeId=fa7e2021e04eb, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Sep 24 07:11:28 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952980, encodeId=34f8952980eb, content=是否合理可能还是要看结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Thu Apr 01 06:45:59 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952978, encodeId=910c9529e848, content=阿米卡星试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIRJ8uX1iaKrYl6YIzycoNZg7LibvSCM86rFq9L5JM0jkLJoPh7BPKka0JuiagKxNOfHCG9hbibCFpTQA/132, createdBy=1a801742301, createdName=Jenny6666, createdTime=Thu Apr 01 03:52:57 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036552, encodeId=fdb5103655285, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 01 02:11:28 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952962, encodeId=dec2952962c8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Wed Mar 31 23:24:38 CST 2021, time=2021-03-31, status=1, ipAttribution=)]
    2021-04-01 易水河

    是否合理可能还是要看结果

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1967935, encodeId=533b196e9355c, content=<a href='/topic/show?id=4e3e1952878' target=_blank style='color:#2F92EE;'>#万古霉素粉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19528, encryptionId=4e3e1952878, topicName=万古霉素粉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sat Nov 20 05:11:28 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877755, encodeId=2f4318e775588, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Fri Aug 06 07:11:28 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000753, encodeId=75801000e53d1, content=了解中, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/61a805a96cd14c7db6b101d616e016c1/9edf917c94b7459892b96b58b289c9a4.jpg, createdBy=3a415395963, createdName=杨楠要做大医生, createdTime=Sun Jul 18 23:51:48 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021704, encodeId=fa7e2021e04eb, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Sep 24 07:11:28 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952980, encodeId=34f8952980eb, content=是否合理可能还是要看结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Thu Apr 01 06:45:59 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952978, encodeId=910c9529e848, content=阿米卡星试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIRJ8uX1iaKrYl6YIzycoNZg7LibvSCM86rFq9L5JM0jkLJoPh7BPKka0JuiagKxNOfHCG9hbibCFpTQA/132, createdBy=1a801742301, createdName=Jenny6666, createdTime=Thu Apr 01 03:52:57 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036552, encodeId=fdb5103655285, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 01 02:11:28 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952962, encodeId=dec2952962c8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Wed Mar 31 23:24:38 CST 2021, time=2021-03-31, status=1, ipAttribution=)]
    2021-04-01 Jenny6666

    阿米卡星试试

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1967935, encodeId=533b196e9355c, content=<a href='/topic/show?id=4e3e1952878' target=_blank style='color:#2F92EE;'>#万古霉素粉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19528, encryptionId=4e3e1952878, topicName=万古霉素粉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sat Nov 20 05:11:28 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877755, encodeId=2f4318e775588, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Fri Aug 06 07:11:28 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000753, encodeId=75801000e53d1, content=了解中, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/61a805a96cd14c7db6b101d616e016c1/9edf917c94b7459892b96b58b289c9a4.jpg, createdBy=3a415395963, createdName=杨楠要做大医生, createdTime=Sun Jul 18 23:51:48 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021704, encodeId=fa7e2021e04eb, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Sep 24 07:11:28 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952980, encodeId=34f8952980eb, content=是否合理可能还是要看结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Thu Apr 01 06:45:59 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952978, encodeId=910c9529e848, content=阿米卡星试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIRJ8uX1iaKrYl6YIzycoNZg7LibvSCM86rFq9L5JM0jkLJoPh7BPKka0JuiagKxNOfHCG9hbibCFpTQA/132, createdBy=1a801742301, createdName=Jenny6666, createdTime=Thu Apr 01 03:52:57 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036552, encodeId=fdb5103655285, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 01 02:11:28 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952962, encodeId=dec2952962c8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Wed Mar 31 23:24:38 CST 2021, time=2021-03-31, status=1, ipAttribution=)]
    2021-04-01 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1967935, encodeId=533b196e9355c, content=<a href='/topic/show?id=4e3e1952878' target=_blank style='color:#2F92EE;'>#万古霉素粉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19528, encryptionId=4e3e1952878, topicName=万古霉素粉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sat Nov 20 05:11:28 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877755, encodeId=2f4318e775588, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7db99, createdName=chg121, createdTime=Fri Aug 06 07:11:28 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1000753, encodeId=75801000e53d1, content=了解中, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/61a805a96cd14c7db6b101d616e016c1/9edf917c94b7459892b96b58b289c9a4.jpg, createdBy=3a415395963, createdName=杨楠要做大医生, createdTime=Sun Jul 18 23:51:48 CST 2021, time=2021-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021704, encodeId=fa7e2021e04eb, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Sep 24 07:11:28 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952980, encodeId=34f8952980eb, content=是否合理可能还是要看结果, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Thu Apr 01 06:45:59 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952978, encodeId=910c9529e848, content=阿米卡星试试, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIRJ8uX1iaKrYl6YIzycoNZg7LibvSCM86rFq9L5JM0jkLJoPh7BPKka0JuiagKxNOfHCG9hbibCFpTQA/132, createdBy=1a801742301, createdName=Jenny6666, createdTime=Thu Apr 01 03:52:57 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036552, encodeId=fdb5103655285, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Apr 01 02:11:28 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=952962, encodeId=dec2952962c8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210523/142a30f37658408183d8809217599398/c57fe41ab3e24013b050a573948c3b02.jpg, createdBy=45db5246795, createdName=147d1c98m12暂无昵称, createdTime=Wed Mar 31 23:24:38 CST 2021, time=2021-03-31, status=1, ipAttribution=)]
    2021-03-31 147d1c98m12暂无昵称

    学习了

    0

相关资讯

8岁男孩惨遭货车碾压,骨盆骨折并神经损伤!医生妙手成功手术复位

近日,南方医科大学第三附属医院(下称“南医三院”)创伤骨科收治一名遭受小货车碾压致伤腹盆部的8岁男孩,经过创伤骨科团队术前详细分析及制定方案,成功手术复位,目前男孩恢复良好已经出院。

JCEM:多因素干预对2型糖尿病患者骨折的影响

在不增加2型糖尿病患者骨折风险的情况下,可以实施强化治疗的多因素干预。有吸烟史的男性发生骨折的风险升高,而FRAX评分可预测骨折风险,女性服用吡格列酮可独立增加骨折风险。

BMC Med :5万人超17年随访研究:不吃肉反而更容易骨折!

随着年龄的增长,骨质疏松的患病风险会明显上升。据调查,我国65岁以上老年女性的患病率为51.6%,男性患病率为10.7%,此外,幼儿和成年人的骨折也很普遍,这都给医疗系统和家庭带来了沉重的负担。

JCEM:胰岛素样生长因子-1、骨密度和骨折的关系

该研究的结果支持IGF-1对骨折具有预防作用,可能并部分是由更高的骨密度所介导。

沙雕新闻丨骨科医生掰手腕骨折,给自己开药!掰手腕会骨折吗?

每到年底,总会有一些“沙雕新闻”占领热搜。近日,河南两名骨科医生掰手腕导致骨折的视频走红网络。据了解,这两名骨科医生最后自己给自己开药治疗骨折,让人心疼又好笑。

JCEM:代谢综合症及其组分对骨折的影响

代谢综合症(MetS)及其组分与骨折之间的关联存在性别差异。具有腹部肥胖的女性骨折的风险增加,而具有较高FPG的男性风险较低。